3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Thyroid Neoplasms
1
Rectal Neoplasms
1
Pancreatic Ductal Adenocarcinoma
1
Neuroendocrine Tumors
1
Neoplastic Cells, Circulating
1
Neoplasm Metastasis
1
Myocarditis
1
Multiple Pulmonary Nodules
1
Liver Metastases
1
Hematologic Neoplasms
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Carcinoma, Neuroendocrine
1
Carcinoma, Lobular
1
Breast Neoplasms
1
Interventions
Temozolomide
41
Magnetic Resonance Spectroscopy
21
Radiotherapy
19
Specimen Handling
15
Radiation
12
Bevacizumab
11
Lomustine
9
pembrolizumab
6
fludarabine
5
Surgical Procedures, Operative
5
atezolizumab
4
Nivolumab
4
Ipilimumab
4
Cyclophosphamide
4
Carboplatin
4
Biopsy
4
cemiplimab
3
azeliragon
3
Immunoglobulin G
3
Disulfides
3
Aminolevulinic Acid
3
veliparib
2
trametinib
2
rocakinogene sifuplasmid
2
ribociclib
2
poly ICLC
2
pamiparib
2
olaparib
2
niraparib
2
lutetium Lu 177 dotatate
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Glioblastoma
×
Positron Emission Tomography Computed Tomography
×
90 days
×
Clear all
No trials found.